-
00:15
1.
index 1
-
02:46
2.
METTL3 mRNA was higher in gastric cancer
-
00:53
3.
Knockdown METTL3 inhibited the tumor proliferation
-
00:01
4.
Knockdown METTL3 inhibited the tumor proliferation
-
00:19
5.
Knockdown METTL3 inhibited the tumor proliferation
-
01:33
6.
Knockdown METTL3 inhibited the tumor proliferation
-
00:30
7.
Knockdown METTL3 inhibited the tumor proliferation
-
03:01
8.
Knockdown METTL3 inhibited the tumor proliferation
-
10:44
9.
METTL3 might have m6A-independent oncogenic functions
-
03:07
10.
METTL3 might have m6A-independent oncogenic functions
-
03:32
11.
METTL3 might have m6A-independent oncogenic functions
-
01:43
12.
METTL3 mainly located in cytoplasm in GC cells
-
01:36
13.
Cytoplasmic METTL3 enables its oncogenic activity
-
00:01
14.
Cytoplasmic METTL3 plays a role in translation initiation
-
00:02
15.
Cytoplasmic METTL3 enables its oncogenic activity
-
02:07
16.
Cytoplasmic METTL3 plays a role in translation initiation
-
05:35
17.
METTL3 regulated the translation of transcripts without m6A modification
-
00:02
18.
METTL3 regulated the translation of transcripts without m6A modification
-
00:02
19.
METTL3 regulated the translation of transcripts without m6A modification
-
00:22
20.
METTL3 regulated the translation of transcripts without m6A modification
-
04:20
21.
METTL3 promotes mRNA translation in an m6Aindependent manner
-
05:51
22.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:06
23.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:01
24.
METTL3 interacts with PABPC1 to regulate RNA translation
-
01:48
25.
METTL3 interacts with PABPC1 to regulate RNA translation
-
03:10
26.
METTL3 interacts with PABPC1 to regulate RNA translation
-
03:06
27.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
01:01
28.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
02:25
29.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:59
30.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:01
31.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:16
32.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:36
33.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:44
34.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
01:22
35.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
01:41
36.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:55
37.
Slide 32
-
00:00
38.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
39.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
40.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
41.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
42.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:01
43.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
44.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:01
45.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:33
46.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:00
47.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
48.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
49.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
50.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
51.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
52.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
53.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
54.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
55.
Slide 32
-
00:00
56.
Slide 33
-
03:11
57.
Slide 32
-
00:00
58.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
59.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
60.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
61.
Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
-
00:00
62.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
63.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
64.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
65.
METTL3–PABPC1 complex activates epigenetic regulator translation
-
00:00
66.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:00
67.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:00
68.
METTL3 interacts with PABPC1 to regulate RNA translation
-
00:00
69.
METTL3 promotes mRNA translation in an m6Aindependent manner
-
00:00
70.
METTL3 regulated the translation of transcripts without m6A modification
-
00:00
71.
METTL3 regulated the translation of transcripts without m6A modification
-
00:00
72.
Cytoplasmic METTL3 plays a role in translation initiation
-
00:00
73.
Cytoplasmic METTL3 enables its oncogenic activity
-
00:01
74.
METTL3 mainly located in cytoplasm in GC cells
-
02:47
75.
Cytoplasmic METTL3 enables its oncogenic activity